In the beginning of the 20th century, enzymes with proteolytic activity were classified as peptidases, Erepsin, and proteases. Among these, pepsin, trypsin, and autolytic enzymes were of the protease class. Spleen-derived proteases were poorly characterized until Sven Gustaf Hedin performed several digestion experiments with bovine spleen. He incubated minced bovine spleen under acidic or neutral conditions and characterized two active proteases; the results were published in 1903. The first protease was named α-protease and was active under neutral conditions. The second was named β-protease and was active under acidic conditions. We replicated Hedin's experiments according to his methods and found, by using activity-based probes to visualize proteases, that the historical α-protease is the presentday serine protease cathepsin G (CatG), which is known to be important in several immune processes, including antigen processing, chemotaxis, and activation of surface receptors. The β-protease, however, comprised different proteases including CatX, B, S, and D. We suggest that Hedin described CatG activity in bovine spleen over 100 years ago.
InTRoDuCTIon
Proteolytic enzymes are generally broadly classified as proteases, but in 1915, the classification of such enzymes was based on more specific substrates and included peptidases (digest polypeptides), Erepsin (digest peptones), and proteases (degrade proteins). Pepsin, trypsin, and autolytic enzymes were classified as proteases (Hedin, 1915) . Towards the end of the 19th century, various scientists concentrated their research on autolytic enzymes. For example, in 1890, Salkowski found increased nitrogenous substances during long-term incubation of liver, muscles, and suprarenal glands at body temperature and interpreted his findings as the action of proteolytic enzymes in these tissues (Salkowski, 1890) . Thirteen years later, the Swedish scientist Sven Gustaf Hedin extended Salkowski's results by treating minced bovine spleen with either neutral or acidic medium and analyzing the products of autodigestion. Hedin published his data in 1903, showing that bovine spleen cells harbor at least two different proteolytic enzymes, one active under neutral conditions, which he named α-protease, and the other active under acidic conditions, which he named b-protease (Hedin, 1903a) .
After discovering these two proteases in bovine spleen, Hedin performed further experiments with bovine serum and concluded that it contained a weak proteolytic enzyme active in neutral medium, the activity of which could be blocked by heating at 55 °C or neutralized by antibodies (also named anti-enzymes at the time) present in the serum. Hedin assumed that the α-protease in bovine spleen-derived leukocytes was similar to the protease found in serum. He further speculated that the α-protease may derive from lysed leukocytes or leukocytes that secrete proteases (Hedin, 1903b) .
In another experiment, Hedin mixed bovine pancreasderived trypsin with normal serum and added casein as a substrate. The serum had a neutralizing effect. Therefore, the data obtained were called Reihenfolgephänomen (i.e., order phenomenon), and the optimum temperature of neutralization was determined to be 37 °C (Hedin, 1905) . Hedin concluded that antibodies were necessary for the anti-tryptic activity because previous antibody publications had reported anti-tryptic effects (Landsteiner, 1900; Cathcart, 1904) . Hedin defined a general principle by preincubating trypsin with serum at 37 °C before adding the substrate. This successive procedure, which he established 100 years ago, is the standard protocol for biochemical inhibition of proteases.
Moreover, Hedin stated that inside leukocytes, proteases were involved in "digesting processes" (Hedin, 1903a) . Phagocytosis, with credit given to Metchnikoff, appears intracellularly in so-called "digesting vacuoles" with acidic pH (Metchnikoff, 1884; 1901) . The conclusions they proposed were precise and prophetic. Antigen processing occurs inside cells and is executed by proteases. A gastric mucosa protease was named cathepsin (gr. καθεφειν to digest) and was proposed to have its origin in leukocytes in the late 1920s (Willstätter, 1929) . Lysosomes were not discovered until 1955 (De Duve et al., 1955; Novikoff et al., 1956) , and a 28 kDa protease, active in alkaline pH, named cathepsin G (CatG), was isolated from human spleen in 1976 (Starkey & Barrett, 1976) .
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The function of cathepsins in the endocytic compartment (endosome and lysosome) within antigen-presenting cells (APC) is to digest antigens into antigenic peptides capable of binding to major histocompatibility complex (MHC) class II molecules. These MHC II antigenic peptide complexes migrate to the cell surface, activate respective T cells, and cause an immune response. Cysteine (CatB, C, F, H, S, X, V, L) and asparagine endoprotease (Watts et al., 2005; Turk & Turk, 2009) , serine (CatA (Reich et al., 2010) and CatG ), and apartyl (CatD and CatE) proteases are involved in antigen processing of different APC (for review, see Colbert et al., 2009) . The serine proteases CatG, neutrophil elastase, and proteinase 3 are highly expressed in granulocytes and can be secreted into the blood by these cells under inflammatory conditions (Meier et al., 1985) . CatG is important in the processing of antigens in primary APC (Reich et al., 2009a) , has anti-bacterial capacity (Ohlsson et al., 1977) , regulates chemotaxis (Nufer et al., 1999) , activates the protease-activated receptor 4 (Sambrano et al., 2000) , and is inhibited by thrombospondin 1 present in the serum or by serpins found in cells (Bornstein et al., 1991; Heutinck et al., 2010) .
The spleen is the body's largest filter of blood and functions to promote the innate and adaptive immune response. The red pulp of the spleen is responsible for clean-up of older erythrocytes and effective iron recycling. The white pulp is formed by sheathed lymphoid tissue composed of T and B cell compartments that facilitate T cell interactions with dendritic cells (DC) and mediate B cell expansion, respectively. APC from the bloodstream enter the white pulp through the marginal zone and initiate a potent adaptive immune response. We replicated Hedin's 1903 experiment by analyzing protease activity after treatment of bovine spleen with neutral or acidic medium. Activity-based probes and Western blotting were used to determine the presence of cysteine, aspartyl, or serine proteases in the collected filtrates. We found that CatG was abundant in the fraction which Hedin described as filtrate B (F B ; Fig. 1 ). Thus, we provide evidence, using several biochemical methods, that Hedin's α-protease, first described in 1903, was most likely CatG. The β-protease described by Hedin reflected the activity of several proteases, including CatX, B, S, and D.
MATERIAlS AnD METHoDS

Cells.
Human peripheral blood mononuclear cells (PBMC) from buffy coats of healthy human cytomegalovirus-seronegative blood donors and bovine spleen cells were isolated by density gradient (Ficoll-Paque TM Plus, GE Healthcare, Uppsala, Sweden) centrifugation.
Preparation of bovine and murine spleens. Freshly isolated bovine, mouse (C57BL/6), or rat (Wistar) spleens were processed on the same day. The spleens were sliced and wire-extruded in phosphate-buffered saline (PBS) followed by incubation with 0.2 % acetic acid (pH 4) for 16 h at room temperature. Subsequently, this acidic solution was filtered, and the filtrate (filtrate A, F A ) was collected and frozen at -20 °C for further analysis. The residue (residue A, R A ) was incubated with 5 % NaCl and adjusted to pH 7.0 for another 16 h at 37 °C. This neutral solution was filtered, and the filtrate (filtrate B, F B ) and residue (residue B, R B ) were collected and stored at -20 °C for further use. The protein content of all filtrates was determined by Bradford assay.
Active site labeling and Western blotting. PBMC and spleen cells were lysed (10 mM Tris, pH 7.5, 150 mM NaCl, and 0.5% NP-40) and adjusted to equal total protein concentration (quantified by Bradford assay), and 20 µg of the cell lysate or filtrates were incubated with PBS (pH 7.4) in the presence of DAP (DAP22c, 2 µM) (Oleksyszyn & Powers, 1991; Reich et al., 2009a) . Alternatively, 5 µg of cell lysate or filtrates were incubated with reaction buffer (1 mM EDTA, 50 mM citrate, pH 5.0, and 50 mM DTT) in the presence of DCG-04 (10 µM; probe kindly donated by M. Bogyo, Stanford University, Palo Alto, CA, USA) (Greenbaum et al., 2000) for 1 h at room temp. Some of the samples were treated with CatG inhibitor I (CatG inhibitor, 10 µM, Calbiochem, Merck, Darmstadt, Germany), Suc-Val-ProPhe P (OPh) 2 (Suc-VPF, 10 µM, (Oleksyszyn and Powers, 1991) ), Z-Arg-Leu-Arg-α-aza-glycyl-Ile-Val-OMe (10 µM, ZRLR, (Wieczerzak et al., 2007) ), phenylmethylsulfonyl fluoride (PMSF, 2 mM, Sigma-Aldrich, Steinheim, Germany), or morpholinurea-leucine-homophenylalaninevinyl phenyl sulfone (LHVS, 20 nM, H. Kalbacher, University of Tübingen, Germany) and pre-incubated for 15 min at 37 °C. Purified CatG from human sputum was purchased from Sigma-Aldrich and 50 ng was used in all experiments. Samples were resolved by 12 % sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS/PAGE), blotted, and visualized using streptavidinhorseradish peroxidase (HRP, Vectastain, Burlingame, CA, USA). For Western blotting, 20 µg of protein from crude cell extracts was loaded on SDS/PAGE, and the immune blot was performed using anti-CatD antibody (Calbiochem, Schwalbach, Germany) or anti-CatX (R&D Systems, Wiesbaden, Germany). Anti-β-actin antibody and secondary HRP-conjugated antibodies were obtained from Sigma-Aldrich (Taufkirchen, Germany).
Determination of CatG activity. Kinetic measurement of CatG activity was accomplished by adding 15 mg of the indicated samples to the colorimetric substrate Suc-Val-Pro-Phe-pNA (200 mM) in buffer (0.5 M MgCl 2 in PBS, pH 7.4). The colorimetric substrate was prepared as followed: Boc-Phe-OH (Iris-biotech, Marktredwitz, Germany) was reacted with p-nitro aniline to give starting Boc-Phe-pNA (Rijkers et al., 1995) . Further deprotection steps and coupling were performed in solution using 50 % trifluoroacetic acid (TFA, Iris-biotech) in dichloromethane (DCM, Iris-biotech) solution (for Boc deprotection) and O-benzotriazole-N,N,N',N'-tetramethyl-uronium-hexafluoro-phosphate (HBTU, as the coupling agent, Iris-biotech), respectively. Introduction of succinamide function was done by an application of succinic anhydride (Sigma-Aldrich, Poznań, Poland) in the presence of N,N-diisopropylethylamine (DIPEA, Iris-biotech). Final product was purified using HPLC chromatography (Econosphere TM C-18 column, Grace, Poznań, Poland). The enzyme assays were performed at 37 °C in duplicate, and absorbance was determined at 405 nm (absorbance microplate reader, EL808, BioTek, Winooski, VT, USA).
RESulTS AnD DISCuSSIon
Spleen preparation according to Hedin's protocol S. G. Hedin described two proteases, one active in acidic, and the other in neutral medium. For those studies, he incubated minced bovine spleen in 2 liters of 0.2 % acetic acid for 16 h at room temp. Chloroform and toluol were added to the mixture in order to pre-vent fermentation. Afterwards, the product was filtered to obtain residue A (R A ) and filtrate A (F A ) (Fig. 1A) . R A was extensively washed with water until no acid reaction was acquired and finally, 2 liters of a 5 % NaCl solution was added for an additional 16 h at 37 °C. After this incubation, the fluid was filtered a second time to obtain R B and F B . The protein degradation of filtrates F A and F B was determined with tannic acid, which precipitates peptones (a mixture of peptides and amino acids), allowing the volume of the precipitate before and after the incubation time to be quantified. The volume thus corresponds to the digestion and proteolytic activity in the respective samples.
In our experiments, whole, freshly isolated bovine spleen was wire-extruded and treated with acetic acid for 16 h (Fig. 1B) . The fluid was filtered to obtain R A and F A . R A was further treated with NaCl, pH-adjusted to 7.0, and incubated for an additional 16 h at 37 °C. F A was directly prepared for analysis (Fig. 2) . After R A incubation, the suspension was filtered into R B and F B .
Identification of active serine proteases in the respective filtrates
To determine the content of active serine proteases in different filtrates, the same amount of protein from 
A B
each sample was pre-incubated with the activity-based probe α-aminoalkylphosphonate diphenyl ester (DAP). The phosphonate inhibitor DAP covalently binds to the active site serine residue of serine proteases and thus allows for visualization of active serine proteases via streptavidin-HRP labeling. Streptavidin functions as a bridge between HRP and biotin from DAP. Active CatG migrated at 28 kDa in F B , in contrast to the crude spleen extracts, in which we only detected low levels of CatG activity ( Fig. 2A) . Approximately 2.5 ng of CatG was detected in 1 µg of F B , which was quantified by comparing a known amount of purified CatG (50 ng) with F B . This indicates that CatG is the predominant protease in this fraction. In F A , CatG activity was not detectable. Notably, we did not detect b-actin in F A or F B , most likely due to degradation by proteases during the incubation period specified by Hedin's protocol. In a separate experiment, fractions F A and F B were centrifuged to obtain cell pellets and supernatant to determine whether CatG could be detected in these fractions. Part of the F A pellet was treated with detergent (NP-40), and F B was separated into cell pellet and supernatant. However, we did not detect any CatG in F A treated with NP-40 or in R B , and CatG activity did not differ between the F A pellet and F A supernatant (Fig. 2B) . CatG activity in bovine spleen was then investigated in greater detail. We used the broadspectrum serine protease inhibitor phenylmethylsulfonyl fluoride (PMSF), a reversible CatG inhibitor (CatG inhibitor), or the irreversible CatG inhibitor Suc-ValPro-Phe P (OPh) 2 (Suc-VPF). Both F B and Ficoll-purified spleen leukocytes were pre-incubated with the indicated inhibitors. CatG activity was completely inhibited by PMSF and SucVPF but not entirely by the reversible CatG inhibitor in either F B or Ficoll-purified spleen cells, which might account for the difference between human, mouse, and rat as compared to bovine CatG (Fig. 2C,  Supplementary Data A) . Inhibition of serine proteases by PMSF in the crude spleen extract demonstrated that different active serine proteases, migrating at 50, 45, 40, and 37 kDa, were present in this extract.
With further analysis using the colorimetric substrate Suc-VPF-pNA, we confirmed that CatG is active in F B , but not in F A , ( Fig. 2D ; for rat and mouse spleen, compare Supplementary Data A, B, and C). These results indicate that the serine protease migrating at 28 kDa in F B is CatG.
Determination of cysteine proteases and CatD
Cysteine proteases were analyzed using a similar approach as described above. Biotinylated DCG-04, a cysteine protease inhibitor based on E64, was used to determine active CatX, B, H, S, and L/C. CatX, B, and S were detected in F A . In contrast, no active CatB, S, or X was found in F B (Fig. 3A) . The allocation of a band to the respective active cathepsins was determined using the specific CatS inhibitor morpholinurea-leucinehomophenylalanine-vinyl phenyl sulfone (LHVS) (Riese et al., 1996) or the CatB-specific inhibitor ZRLR (Wieczerzak et al., 2007; Reich et al., 2009b) (Fig. 3B ; for rat spleen, see Supplementary Data D). E64 was used as a broad cysteine protease inhibitor. Notably, the upper two bands refer to CatX, indicated in the Supplementary section showing the CatX immunoblot (Supplementary Data E) .
Subsequently, the aspartyl protease CatD was analyzed using a CatD-specific immunoblot because of the lack of an active-site label for aspartyl proteases. CatD was (Fig. 4 ; Supplementary Data F). This demonstrates that several proteases, including CatX, CatB, CatS, and CatD, were present in F A . Therefore, Hedin's b-protease consists of multiple proteolytic enzymes, explaining the observation of rapid proteolytic degradation in acidic fluid (Hedin, 1901) . In a later publication, Hedin discussed this issue in more detail and concluded that other proteases active in the acidic medium were present (Hedin, 1923) , which is consistent with our findings. Furthermore, treatment of crude spleen extract with acetic acid for 16 h and for an additional 16 h under neutral conditions resulted in CatG enrichment in F B , suggesting that Hedin's protocol was also practical for concentrating CatG. Notably, Hedin's experimental design of protease inhibition was utilized to categorize inhibitors into anti-enzymes (i.e., antibodies), Hemmungskörper (i.e., blocking body), or inhibitive substances (Hedin, 1915) . The mechanism was explained by absorption as experiments with Kieselgur revealed that the α-protease was not active when bound to Kieselgur (Hedin, 1907) . Another possible explanation for the inhibition is the interaction of normal serum with the protease (Hedin, 1905) . Indeed, Hedin found that only the bovine spleen-derived α-protease, in contrast to b-protease, was inhibited by antibodies in bovine serum and was not neutralized under his experimental conditions (Hedin, 1903a ). The effect he described was most likely the action of serine protease inhibitors (serpins and thrombospondin 1) circulating in the blood (Remold-O'Donnell et al., 1992) . Today, we know that CatG in leukocytes, such as DC and B cells, is not only important in antigen processing, but also in immune defense in the periphery. In conclusion, based on several criteria, we suggest that Hedin described CatG activity in 1903 as the α-protease active in neutral medium. 
